Private Advisor Group’s Armata Pharmaceuticals ARMP Stock Holding History

Private Advisor Group’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-73	Closed	–	–	1674
2020 Q2	$0	Buy	+73	New	+$253	﹤0.01%	3837

Other funds holding ARMP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWM

SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Private Advisor Group's ARMP Position: Q3 2020 in Review

Private Advisor Group sold out of Armata Pharmaceuticals (ARMP) in Q3 2020, closing a stake of 73 shares.

Private Advisor Group first reported a position in ARMP in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 21 funds tracked by Wall St. Rank hold ARMP as of Q3 2020.

Private Advisor Group reported no remaining Armata Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 73 Armata Pharmaceuticals shares in Q3 2020.
Private Advisor Group first reported a position in Armata Pharmaceuticals in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Armata Pharmaceuticals position peaked at $0 in Q2 2020.
21 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.